JHVEPhoto/iStock Editorial via Getty Images Investment Thesis AECOM (NYSE:ACM) is well-positioned to continue delivering good growth ahead. The company's revenue growth should benefit from a healthy backlog of $23.7 billion. In addition, increasing PFAS-related work, the company's exposure to high-growth markets, and healthy infrastructure investments globally should also increase revenue growth. On the margin front, the company should benefit from improving international margins, operating leverage, and co ...